[go: up one dir, main page]

AR025799A1 - Articulo absorbente que posee medios de defensa elastizados y metodos para su fabricacion - Google Patents

Articulo absorbente que posee medios de defensa elastizados y metodos para su fabricacion

Info

Publication number
AR025799A1
AR025799A1 ARP960103082A AR60103082A AR025799A1 AR 025799 A1 AR025799 A1 AR 025799A1 AR P960103082 A ARP960103082 A AR P960103082A AR 60103082 A AR60103082 A AR 60103082A AR 025799 A1 AR025799 A1 AR 025799A1
Authority
AR
Argentina
Prior art keywords
continuous
absorbent
barrier
internal
manufacturing process
Prior art date
Application number
ARP960103082A
Other languages
English (en)
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of AR025799A1 publication Critical patent/AR025799A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06086—Dipeptides with the first amino acid being basic
    • C07K5/06095—Arg-amino acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Un articulo absorbente incluye una barrera contra la humedad, un revestimiento contacto-cuerpo enlazado a la barrera contra la humedad y una estructuraabsorbente dispuesta entre el revestimiento cotnacto cuerpo y la barrera cotnra la humedad y unaes tructura absorbente dispuesta entre el revestimientocontacto cuerpo y la barrera contra la humedad. Los medios de defensa elastizados, que funcionan como barreras físicas tridimensionales contra el movimiento delíquidos, están ubicados en losmárgene s del artículo. Los medios de defensa elastizados incluyen una estructura interna de barrera y una cobertura elastizadadispuesta sobre la estructura interna de barrera y enlazada a uno de los márgenes. En realizaciones particulares, lacobertura elas tizada está formada por unmaterial hidrofobo, no está adherida a la estructura interna de barrera y/o está compuesta por hebras elásticas de grados de fuerza variables. Un método derealizacion de un artículo absorbente incluye lospasos de provision de un tejido transportador continuo que posee bordes laterales opuestos y disposicion deun tejido absorbente continuo sobre el tejido transportador continuo entre los bordes laterales. Las hebras continuas de un material internode barrera estándispu estas sobre el tejido absrobente y cada uno de los bordes laterales. El tejido transportador continuo, el tejido absorbente y las hebras de materialinterno de barrera forman una estructura compuesta continua durante el procesode fabricacion la cual se corta en forma transversal a los efectos de formar unapluralidad de estructuras compuestas individuales durante el proceso de fabricacion. Cada estructura compuesta individual durante el proceso de fabricacionincluye unaestructura absorbente y un par de estructuras internas de barrera dispuestas sobre una lámina transportadora. El método también incluye ladisposicion de estructuras compuestas individuales durante el proceso de fabricacion de un tejido continuo debarrera contra la humedad y la provision de unpar de coberuras continuas. Las coberturas continuas están elastizadas sobre, como mínimo, parte de su longitud y están ubicadas sobre las estructuras internas
ARP960103082A 1995-06-07 1996-07-06 Articulo absorbente que posee medios de defensa elastizados y metodos para su fabricacion AR025799A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/486,010 US6069130A (en) 1995-06-07 1995-06-07 Ketoheterocyclic inhibitors of factor Xa

Publications (1)

Publication Number Publication Date
AR025799A1 true AR025799A1 (es) 2002-12-18

Family

ID=23930257

Family Applications (2)

Application Number Title Priority Date Filing Date
AR10308396A AR003004A1 (es) 1995-06-07 1996-06-07 Inhibidores cetoheterociclicos del factor xa.
ARP960103082A AR025799A1 (es) 1995-06-07 1996-07-06 Articulo absorbente que posee medios de defensa elastizados y metodos para su fabricacion

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AR10308396A AR003004A1 (es) 1995-06-07 1996-06-07 Inhibidores cetoheterociclicos del factor xa.

Country Status (9)

Country Link
US (2) US6069130A (es)
EP (1) EP0832102A1 (es)
JP (1) JPH11507337A (es)
AR (2) AR003004A1 (es)
AU (1) AU702360B2 (es)
CA (1) CA2224180A1 (es)
NZ (1) NZ312840A (es)
WO (1) WO1996040744A1 (es)
ZA (1) ZA964754B (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0813525T3 (da) * 1995-03-10 2004-02-16 Berlex Lab Benzamidinderivater, deres fremstilling og anvendelse som antikoagulanter
US6069130A (en) * 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US6008234A (en) * 1996-09-12 1999-12-28 Berlex Laboratories, Inc. Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants
US6194435B1 (en) 1996-10-11 2001-02-27 Cor Therapeutics, Inc. Lactams as selective factor Xa inhibitors
US6063794A (en) 1996-10-11 2000-05-16 Cor Therapeutics Inc. Selective factor Xa inhibitors
US6262047B1 (en) 1996-10-11 2001-07-17 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6369080B2 (en) 1996-10-11 2002-04-09 Cor Therapeutics, Inc. Selective factor Xa inhibitors
WO1998028326A1 (en) * 1996-12-23 1998-07-02 Biochem Pharma Inc. Bicyclic thrombin inhibitors
WO1998046626A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. SELECTIVE FACTOR Xa INHIBITORS
CA2285705A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. Selective factor xa inhibitors
CA2285659A1 (en) * 1997-04-14 1998-10-22 Cor Therapeutics, Inc. Selective factor xa inhibitors
WO1998051684A1 (en) 1997-05-15 1998-11-19 Eli Lilly And Company Antithrombotic compound
US6333321B1 (en) 1997-08-11 2001-12-25 Cor Therapeutics, Inc. Selective factor Xa inhibitors
US6218382B1 (en) 1997-08-11 2001-04-17 Cor Therapeutics, Inc Selective factor Xa inhibitors
US6228854B1 (en) 1997-08-11 2001-05-08 Cor Therapeutics, Inc. Selective factor Xa inhibitors
CA2334476A1 (en) 1998-06-08 1999-12-16 Ajinomoto Co., Inc. Benzamidine derivative
EA200100815A1 (ru) * 1999-01-27 2002-08-29 Орто-Макнейл Фармасьютикал, Инк. Пептидильные гетероциклические кетоны, применимые в качестве ингибиторов триптазы
WO2000051998A1 (en) 1999-03-02 2000-09-08 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as reversible inhibitors of cathepsin s
JP2002538226A (ja) * 1999-03-11 2002-11-12 デュポン ファーマシューティカルズ カンパニー Ｘａ因子阻害剤およびアスピリン、組織プラスミノーゲンアクチベータ（ＴＰＡ）、ＧＰＩＩｂ／ＩＩＩａ拮抗剤、低分子量ヘパリンまたはヘパリンの組合せ使用による血栓症の治療
US6794412B1 (en) 1999-03-11 2004-09-21 Bristol-Myers Squibb Pharma Company Treatment of thrombosis by combined use of a factor Xa inhibitor and aspirin
TW200404789A (en) * 1999-03-15 2004-04-01 Axys Pharm Inc Novel compounds and compositions as protease inhibitors
CA2367348A1 (en) 1999-03-15 2000-09-21 Axys Pharmaceuticals, Inc. Novel compounds and compositions as protease inhibitors
EP1516877A1 (en) * 1999-03-15 2005-03-23 Axys Pharmaceuticals, Inc. Amine derivatives as protease inhibitors
US6420364B1 (en) 1999-09-13 2002-07-16 Boehringer Ingelheim Pharmaceuticals, Inc. Compound useful as reversible inhibitors of cysteine proteases
WO2002006280A2 (en) * 2000-07-13 2002-01-24 Millennium Pharamaceuticals, Inc. INHIBITORS OF FACTOR Xa
MXPA03005601A (es) 2000-12-22 2004-12-02 Axys Pharm Inc Nuevos compuestos y composiciones como inhibidores de catepsina.
US7030116B2 (en) 2000-12-22 2006-04-18 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin inhibitors
RS19504A (sr) 2001-09-14 2007-02-05 Aventis Pharmaceuticals Inc., Nova jedinjenja i kompozicije kao inhibitori katepsina
US6977256B2 (en) 2001-11-14 2005-12-20 Aventis Pharmaceuticals Inc. Compounds and compositions as cathepsin S inhibitors
DK1569912T3 (en) 2002-12-03 2015-06-29 Pharmacyclics Inc 2- (2-hydroxybiphenyl-3-yl) -1h-benzoimidazole-5-carboxamidine derivatives as factor VIIa inhibitors.
EP2027143A2 (en) 2006-05-23 2009-02-25 Irm Llc Compounds and compositions as channel activating protease inhibitors
WO2008097676A1 (en) 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3867364A (en) * 1968-11-21 1975-02-18 Microbial Chem Res Found Process for the synthesis of leupeptins and their analogues
HU177098B (en) * 1979-01-04 1981-07-28 Gyogyszerkutato Intezet Process for producing new peptidyl-n-carboxy-l-arginin-a
NO812612L (no) * 1980-08-06 1982-02-08 Ferring Pharma Ltd Enzym-inhibitorer.
HU184368B (en) * 1981-01-13 1984-08-28 Gyogyszerkutato Intezet Process for preparing d-phenyl-alanyl-l-propyl-l-arginine-ald ehyde-shulphate
US4588587A (en) * 1983-03-01 1986-05-13 Pennsylvania Hospital Method of treatment to inhibit metastasis
GB8312339D0 (en) * 1983-05-05 1983-06-08 Austen B M Peptides
ZA86746B (en) * 1985-02-04 1986-09-24 Merrell Dow Pharma Novel peptidase inhibitors
NZ223148A (en) * 1987-01-16 1989-10-27 Merrell Dow Pharma Peptide derivatives having peptidase inhibition activity
IL86856A0 (en) * 1988-06-24 1988-11-30 Yissum Res Dev Co Bovine xa factor and pharmaceutical compositions containing the same
ZA897514B (en) * 1988-10-07 1990-06-27 Merrell Dow Pharma Novel peptidase inhibitors
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
NZ235155A (en) * 1989-09-11 1993-04-28 Merrell Dow Pharma Peptidase substrates in which the carboxy terminal group has been replaced by a tricarbonyl radical
JPH0813834B2 (ja) * 1990-08-01 1996-02-14 日東紡績株式会社 トリペプチド誘導体及びそれを有効成分とする蛋白分解酵素阻害剤
US5430023A (en) * 1990-09-28 1995-07-04 Eli Lilly And Company Tripeptide antithrombotic agents
IL99527A (en) * 1990-09-28 1997-08-14 Lilly Co Eli Tripeptide antithrombotic agents
CA2075154A1 (en) * 1991-08-06 1993-02-07 Neelakantan Balasubramanian Peptide aldehydes as antithrombotic agents
CA2128711C (en) * 1992-01-30 2005-01-11 Terence K. Brunck Trypsin inhibitors
EP0627929B1 (en) * 1992-02-14 1998-09-30 Corvas International, Inc. Inhibitors of thrombosis
US5371072A (en) * 1992-10-16 1994-12-06 Corvas International, Inc. Asp-Pro-Arg α-keto-amide enzyme inhibitors
ATE177752T1 (de) * 1992-12-15 1999-04-15 Corvas Int Inc Neue inhibitoren von faktor xa
DE69419141D1 (de) 1993-02-12 1999-07-22 Corvas Int Inc Inhibitoren gegen thrombose
AU670381B2 (en) * 1993-04-30 1996-07-11 Merck & Co., Inc. Thrombin inhibitors
JP3388803B2 (ja) * 1993-05-20 2003-03-24 第一製薬株式会社 光学活性７−アミジノナフタレン誘導体の製造法
EP0648780A1 (en) * 1993-08-26 1995-04-19 Bristol-Myers Squibb Company Heterocyclic thrombin inhibitors
IL111175A0 (en) * 1993-10-07 1994-12-29 Du Pont Merck Pharma Electrophilic peptide analogs as inhibitors of trypsin-like serine proteases and pharmaceutical compositions containing them
SI9520044B (sl) * 1994-04-26 2004-08-31 Aventis Pharmaceuticals Inc. Inhibitorji Xa faktorja
US5637599A (en) 1994-06-17 1997-06-10 Corvas International, Inc. Arginine mimic derivatives as enzyme inhibitors
US6025472A (en) * 1994-12-21 2000-02-15 Corvas International, Inc. N-substituted glycine derivatives as enzyme inhibitors
JPH10513151A (ja) 1994-12-22 1998-12-15 バイオケム ファーマ インコーポレイテッド トロンビン阻害剤としての複素環式ケトアルギニンペプチド
US6069130A (en) * 1995-06-07 2000-05-30 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5523308A (en) * 1995-06-07 1996-06-04 Costanzo; Michael J. Peptidyl heterocycles useful in the treatment of thrombin related disorders
US6022861A (en) * 1995-06-07 2000-02-08 Cor Therapeutics, Inc. Ketoheterocyclic inhibitors of factor Xa
US5612369A (en) 1995-06-07 1997-03-18 3-Dimensional Pharmaceuticals, Inc. Thrombin inhibitors

Also Published As

Publication number Publication date
MX9709908A (es) 1998-07-31
ZA964754B (en) 1997-03-11
WO1996040744A1 (en) 1996-12-19
US6197748B1 (en) 2001-03-06
AU6476196A (en) 1996-12-30
AR003004A1 (es) 1998-05-27
US6069130A (en) 2000-05-30
NZ312840A (en) 1999-11-29
EP0832102A1 (en) 1998-04-01
AU702360B2 (en) 1999-02-18
CA2224180A1 (en) 1996-12-19
JPH11507337A (ja) 1999-06-29

Similar Documents

Publication Publication Date Title
AR025799A1 (es) Articulo absorbente que posee medios de defensa elastizados y metodos para su fabricacion
KR890009316A (ko) 신축성 흡수 내의
RU2000112640A (ru) Поглощающее изделие, обладающее повышенной эластичностью и позволяющее улучшить эстетические характеристики и способность удержания
CO4750790A1 (es) Articulo absorbente que tiene una barrera de humedad en la region de cintura y metodo para su fabricacion
AR009695A1 (es) Articulo absorbente
SE8404023L (sv) Skottseker platta
UY23923A1 (es) Articulo absorbente con un mejorado control de humedecimiento
ES8501463A1 (es) Un procedimiento para conformar un articulo compuesto estirable que tiene al menos dos capas, en particular un tejido
ES2194333T3 (es) Articulo absorbente de forma estable.
ES506042A0 (es) Procedimiento para la fabricacion en continuo de prendas destinadas a un solo uso
JP2001252303A5 (es)
PE10097A1 (es) Lamina de revestimiento para un articulo absorbente y metodo para producir la misma
RU98112334A (ru) Содержащее абсорбент изделие с усовершенствованными эластичными краями и с удерживающей системой
PE77899A1 (es) Barreras a los liquidos en articulos absorbentes
ES8700029A1 (es) Panal para bebe
AR031917A1 (es) Producto absorbente con barreras protectoras contra fugas
PE2297A1 (es) Articulo absorbente con miembro de contacto con el cuerpo para control del liquido y metodo de fabricacion
AR005011A1 (es) Articulo absorbente descartable con calce mejorado.
AR003389A1 (es) Articulo absorbente que tiene lados longitudinales y extremos transversales, una superficie que roza al cuerpo y una superficie que roza a laprenda
ES2069342T3 (es) Revestimiento de pared acusticamente activo para automoviles.
AR038407A1 (es) Calzoncillo tipo panal
ES2122130T3 (es) Panel de material plastico, proceso y dispositivo para su fabricacion.
PE73698A1 (es) Sistema de sujecion reforzado de monofilamento para articulos absorbentes y metodo de fabricacion
PE9698A1 (es) Articulo absorbente con protecciones elasticadas
ES2144529T3 (es) Pañal desechable.